<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - New Report Highlights Risks of U.S. Drug Reimportation
Image Overlay - New Report Highlights Risks of U.S. Drug Reimportation

Joint Oncologie and Merck Phase II Trial Announced for Gastric and Gastroesophageal Cancers

September 9, 2019

New Report Highlights Risks of U.S. Drug Reimportation

Oncologie and Merck will launch a phase II trial to investigate Merck’s Keytruda (pembrolizumab) and Oncologie’s bavituximab, an antibody that blocks the activity of phosphatidylserine (PS) in advanced gastric or gastroesophageal cancer. International trials like this one — enrolling patients in the United States, the UK, Korea, and Taiwan — are a particular specialty at Yourway.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Media

Articles

Maintaining Temperature Integrity in Direct-to-Patient Clinical Trials

Open chat
Come chat with us!
Hello! How can I help you?